Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)

PROCEPT BioRobotics has reported Preferred Stock Liabilities over the past 2 years, most recently at $328.6 million for Q2 2021.

  • Quarterly results put Preferred Stock Liabilities at $328.6 million for Q2 2021, changed N/A from a year ago — trailing twelve months through Jun 2021 was $328.6 million (changed N/A YoY), and the annual figure for FY2020 was $243.9 million, changed.
  • Preferred Stock Liabilities for Q2 2021 was $328.6 million at PROCEPT BioRobotics, up from $243.9 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for PRCT hit a ceiling of $328.6 million in Q2 2021 and a floor of $243.9 million in Q3 2020.